|
KTI12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.36749999990471E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.79600000000035E-05 |
| Normal-vs-Stage2 |
2.153700E-02 |
| Normal-vs-Stage3 |
3.339800E-03 |
| Normal-vs-Stage4 |
1.056400E-01 |
| Stage1-vs-Stage2 |
4.115400E-01 |
| Stage1-vs-Stage3 |
2.368000E-01 |
| Stage1-vs-Stage4 |
9.546400E-01 |
| Stage2-vs-Stage3 |
7.586200E-01 |
| Stage2-vs-Stage4 |
6.782200E-01 |
| Stage3-vs-Stage4 |
5.039200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.80880000042205E-07 |
| Normal-vs-AfricanAmerican |
7.242100E-04 |
| Normal-vs-Asian |
4.264200E-01 |
| Caucasian-vs-AfricanAmerican |
9.587400E-01 |
| Caucasian-vs-Asian |
9.022600E-01 |
| AfricanAmerican-vs-Asian |
8.958000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.28060000001729E-06 |
| Normal-vs-Female |
2.00819999995883E-06 |
| Male-vs-Female |
5.491700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.276700E-03 |
| Normal-vs-Extreme_Weight |
6.14759999999492E-05 |
| Normal-vs-Obese |
4.169300E-04 |
| Normal-vs-Extreme_Obese |
9.137800E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.387800E-01 |
| Normal_Weight-vs-Obese |
7.103200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.456800E-01 |
| Extreme_Weight-vs-Obese |
6.063200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.053600E-01 |
| Obese-vs-Extreme_Obese |
9.957800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.553000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.04569999618221E-08 |
| Normal-vs-Age(61-80Yrs) |
6.36099999999917E-05 |
| Normal-vs-Age(81-100Yrs) |
1.835370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.272800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.279600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.965200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.247220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.591200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.555000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.64609994710719E-09 |
| Normal-VS-Type2 PRCC |
1.381690E-03 |
| Normal-VS-KIRP CIMP |
1.274400E-01 |
| Normal-VS-Unclassified PRCC |
9.236600E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.170000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.443500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.278800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.038400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.692000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.800800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.217800E-03 |
| Normal-vs-N1 |
7.475200E-03 |
| Normal-vs-N2 |
6.212200E-01 |
| N0-vs-N1 |
2.448800E-01 |
| N0-vs-N2 |
9.672800E-01 |
| N1-vs-N2 |
6.819800E-01 |
|
|
